Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $1.1 million.

  • Sanara MedTech's Free Cash Flow fell 4528.4% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$842048.0, marking a year-over-year increase of 5773.52%. This contributed to the annual value of -$229632.0 for FY2024, which is 9345.93% up from last year.
  • Sanara MedTech's Free Cash Flow amounted to $1.1 million in Q3 2025, which was down 4528.4% from $902652.0 recorded in Q2 2025.
  • Sanara MedTech's Free Cash Flow's 5-year high stood at $2.0 million during Q3 2024, with a 5-year trough of -$3.7 million in Q1 2025.
  • In the last 5 years, Sanara MedTech's Free Cash Flow had a median value of -$1.3 million in 2021 and averaged -$848980.8.
  • Per our database at Business Quant, Sanara MedTech's Free Cash Flow tumbled by 23502.9% in 2022 and then skyrocketed by 19524.45% in 2024.
  • Sanara MedTech's Free Cash Flow (Quarter) stood at -$1.9 million in 2021, then skyrocketed by 63.74% to -$698380.0 in 2022, then dropped by 29.27% to -$902808.0 in 2023, then skyrocketed by 195.24% to $859875.0 in 2024, then increased by 29.9% to $1.1 million in 2025.
  • Its Free Cash Flow was $1.1 million in Q3 2025, compared to $902652.0 in Q2 2025 and -$3.7 million in Q1 2025.